MED DISCOVERY SA
Route de la Corniche 4
1066 Epalinges - Switzerland
Tél +41 21 651 90 76 - Email
Dr. Kündig obtained his Ph.D. in life sciences at the Swiss Institute of Technology in Zurich, Switzerland. He joined Professor Marc Ouellette's laboratory at Laval University (Québec, Canada) in 1994 as post-doctoral fellow. He worked on drug target discovery and the molecular biology of Leishmaniosis. He then joined Essential Therapeutics Inc. Company in Mountain View, California as Senior Research Scientist. Med Discovery hired Dr. Kündig as R&D Director at the beginning of its R&D activity to head Med Discovery’s drug discovery, early preclinical and CMC operations. In 2010 Dr. Kündig was promoted CSO to manage the transition of its lead projects from preclinical into early clinical development.
Sandra Ferreira made her classes at the Ecole Supérieure de Commerce André-Chavannes in Geneva and obtained her Federal Certificate in 2001. In January 2012, she joined the company to support the management of administration and human resources. She had previously been an executive assistant as well as secretariat and events manager in one of the largest investment fund in Europe (Index Ventures) and in different Biotechs as SpinX Technologies and Dermadis. She has extensive experience in managing high-risk companies and the establishment of their administrative structure.